The Invention of Copper Cysteamine Illuminates Many Areas
Here we introduce a new material called Copper Cysteamine we invented for applications in cancer and infection treatment as well as applications in lighting, sensing and water purification. Photodynamic therapy has the beauty of targeting tumors by the sensitizers themselves and the light, however, the need of light for activation has some limitations as light cannot penetrate deeply into tissue, so photodynamic therapy has been widely used for skin disease treatment but not for deep cancer treatment. Here will discuss the possible solutions for developing photodynamic therapy for deep cancer treatment and some new progress in Photodynamic therapy and the invention of new sensitizers that can be activated by UV, X-ray, microwave and ultrasound to produce reactive oxygen species for deep cancer treatment as well as immunity enhancement and the solutions by taking the advantages of the tumor environment. New ideas for the combination of photodynamic therapy and radiation to overcome radiation resistance will be discussed. In addition, the potential applications of this kind of new materials in other areas like water treatment, lighting, sensing and plant growth will be briefly introduced.
In the meantime, I will cover the research activities for the faculty members in my school and discuss the opportunities for potential collaborations.
Date and Time
Location
Hosts
Registration
-
Add Event to Calendar
- University of Western Australia
- Fairway Entrance 2, 3rd Floor
- Crawley, Western Australia
- Australia 6009
- Building: Electrical, Electronic and Computer Engineering Building
- Room Number: 303
Speakers
Dr. Wei Chen
Biography:
Dr. Wei Chen is the dean for the School of CHIPS at the Xi’an Jiaotong-Liverpool University. He held the esteemed position of University Distinguished Professor within the Physics department at the University of Texas Arlington (UTA), Texas, USA. With a prolific academic career, he has authored over 378 publications in renowned scholarly journals, overseeing the compilation of two books, one monograph spanning three volumes, and contributing to the creation of 15 monographs. His works have garnered significant attention, amassing more than 23,832 citations, resulting in an impressive H-index of 79. Notably, Dr. Chen has authored a paper with 841 citations and four others with over 716 citations each. His inventive contributions extend to over 22 granted US patents.
Dr. Chen's groundbreaking scientific endeavors have gained widespread recognition, notably drawing attention from CBS in the USA. In acknowledgment of his outstanding contributions, he received the University Distinguished Record of Research and Creative Activity Award in 2020. His eminence within the field was further solidified by his election as a Fellow of the International Association of Advanced Materials and a Fellow of the Royal Society of Chemistry (UK) in 2021. In 2022, he received the IMMA Scientist Award for his exceptional contributions to Nanotechnology. His remarkable achievements were acknowledged by his election as a Fellow for the US National Academy of Inventors in 2022 and as a member of the University Academy of Distinguished Scholars in 2023, the highest honor and recognition at UTA. Dr. Chen is among the top 2% scientists in the world.
Dr. Chen also served as the Director of the Center for Security Advances Via Applied Nanotechnology (SAVANT) from 2012 to 2018, showcasing his leadership and vision in the field. He used to be the deputy director for the laboratory of Semiconductor Materials at the Institute of Semiconductors, CAS and he received the outstanding young scientist award from CAS.